首都医科大学学报 ›› 2005, Vol. 26 ›› Issue (5): 600-604.

• 妇产科学研究 • 上一篇    下一篇

绝经期乳腺癌妇女服用他莫昔芬后子宫内膜雌、孕激素受体变化及Ki-67的表达

高婉丽1, 冯力民1, 张铭1, 张华2, 孙海梅2   

  1. 1. 首都医科大学附属北京天坛医院妇产科2. 首都医科大学组织胚胎学教研室
  • 收稿日期:2005-08-20 修回日期:1900-01-01 出版日期:2005-10-24 发布日期:2005-10-24
  • 通讯作者: 冯力民

Effects of Tamoxifen on Expression of Oestrogen Receptors,Progesterone Receptors and Ki-67 in Postmenopausal Endometrium

Gao Wanli1, Feng Limin1, Zhang Ming1, Zhang Hua2, Sun Haimei2   

  1. 1. Department of Obstetrics and Gynecology, Beijing Tiantan Hospital, Capital University of Medical Sciences;2. Department of Histology and Embryology, Capital University of Medical Sciences
  • Received:2005-08-20 Revised:1900-01-01 Online:2005-10-24 Published:2005-10-24

摘要:

目的 评估他莫昔芬(TAM)对绝经后妇女子宫内膜的雌激素样作用与性激素受体的改变是否相关,以及细胞增生核抗原Ki-67在子宫内膜中的表达。方法 选择46例绝经后因乳腺癌服用TAM超过6个月妇女的子宫内膜为研究组,同时选择18例绝经后妇女的萎缩型子宫内膜作为对照组。采用免疫组织化学法测定雌激素受体(ER)、孕激素受体(PR)及Ki-67在子宫内膜中的表达。结果 与对照组比较,PR及Ki-67在TAM组内膜腺上皮细胞呈明显高表达(0.46±0.05比0.35±0.06,P=0.028;15.41±4.83比9.05±5.52,P=0.009);ER在TAM组内膜腺上皮细胞虽然呈高表达,但差异无统计学意义(0.47±0.06比0.43±0.06,P=0.063)。结论 绝经后乳腺癌妇女服用TAM后能够引起子宫内膜增生,TAM雌激素样作用与病理诊断和服用时间无关,这可能是子宫内膜息肉及内膜癌的发病机制之一。

关键词: 他莫昔芬, 子宫内膜, 雌激素受体, 孕激素受体, Ki-67抗原

Abstract:

Objective To investigate the effects of tamoxifen(TAM) on expression of oestrogen receptors(ER),progesterone receptors(PR)and Ki-67 antigen in postmenopausal endometrium.Methods Forty-six postmenopausal breast cancer patients receiving 20 mg/d TAM for at least six months were examined by hysteroscopy and endometrial biopsy,and eighteen age-matched,non-hormonally treated patients with atrophic endometrium post vaginal hysterectomy because of uterine prolapse served as control groups.Immunohistochemical studies for the expression of ER,PR and Ki-67 antigen in endometrium were performed.Results There were significantly increased levels of expression of PR((0.46±)0.05 vs 0.35±0.06,P=0.028) in glandular epithelium in tamoxifen-associated endometrium compared with atrophic endometrium.Also,Ki-67 antigen was expressed more frequently in glandular epithelium in the tamoxifen samples(15.41±4.83 vs 9.05±5.52,P=0.009).The expression of ER in glandular epithelium was higher but did not differ statistically between tamoxifen-associated endometrium and atrophic endometrium(0.47±0.06 vs 0.43±0.06,P=0.063).Conclusion In postmenopausal women tamoxifen exerts a proliferative effect on the endometrium,as measured by Ki-67 antigen.The tamoxifen-associated changes in endometrial PR support an estrogenic effect that is independent of histological diagnosis and duration.This may contribute to the pathogenesis of tamoxifen-associated polyps and carcinomas.

Key words: tamoxifen, endometrium, oestrogen receptors, progesterone receptors, Ki-67 antigen

中图分类号: